Similar articles

Abstract: Evidence suggests that the deterioration of communication between the sympathetic nervous system and cardiovascular system always accompanies the aging of human and animals. Cardiac sympathetic norepinephrine (NE) transporter (NET) on presynaptic membrane is a predominant component to eliminate released NE in the synaptic cleft and maintains the sensitivity of the β-adrenergic receptor (β-AR). In the present study, we investigated NET and β₁-AR mRNA levels and sympathetic nerve density in cardiac sympathetic ganglion and left ventricular myocardium in 2- and 16-month-old rats with Northern blot analysis and immunohistochemistry. The expression levels of NET mRNA, NET protein and β₁-AR mRNA in the ganglia or myocardia of 16-month-old rats were markedly reduced by 67%, 26%, and 43%, respectively, in comparison with those in 2-month-old rats. Our results also show that aging induces a strong decrease of the catecholaminergic nerve fiber density.

[1] Aggarwal, A., Esler, M.D., Lambert, G.W., Hastings, J., Johnston, L., Kaye, D.M., 2002. Norepinephrine turnover is increased in suprabulbar subcortical brain regions and is related to whole-body. Sympathetic activity in human heart failure. Circulation, 105(9):1031-1033.

[2] Asanuma, M., Kondo, Y., Nishibayashi, E., Iwata, E., Nakanishi, T., Ogawa, N., 1995. Age-related changes in composition of transcription factor, AP-1 complex, in the rat brain. Neurosci. Lett., 201(2):127-130.

[3] Backs, J., Haunstetter, A., Gerber, S.H., Metz, J., Borst, M.M., Strasser, R.H., Kubler, W., Haass, M., 2001. The neuronal norepinephrine transporter in experimental heart failure: evidence for a posttranscriptional downregulation. J. Mol. Cell. Cardiol., 33(3):461-472.

[4] Barkely, R.D., de Felice, L.J., Hartzell, H.C., 1994. Molecular physiology of norepinephrine and serotonin transporters. J. Exp. Biol., 196(1):263-281.

[5] Bohm, M., Castellano, M., Flesch, M., Maack, C., Moll, M., Paul, M., Schiffer, F., Zolk, O., 1998. Chamber-specific alterations of norepinephrine uptake sites in cardiac hypertrophy. Hypertension, 32(5):831-837.

[6] Bristow, M.R., Minobe, W., Rasmussen, R., 1992. β-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J. Clin. Invest., 89(3):803-815.

[7] Bruzzone, P., Cavallotti, C., Mancone, M., Tranquilli Leali, F.M., 2003. Age-related changes in catecholaminergic nerve fibers of rat heart and coronary vessels. Gerontology, 49(2):80-85.

[8] Chevalier, B., Mansier, P., Teiger, E., Amrani, C.F., Swynghedauw, B., 1991. Alterations in beta adrenergic and muscarinic receptors in aged rat heart. Effects of chronic administration of propranolol and atropine. Mech. Ageing Dev., 60(2):215-224.

[9] Dawson, R.Jr., Meldrum, M.J., 1992. Norepinephrine content in cardiovascular tissues from the aged Fischer 344 rat. Gerontology, 38(4):185-191.

[10] Eisenhofer, G., 1994. Plasma normetanephrine for examination of extraneuronal uptake and metabolism of norepinephrine in rats. J. Auton. Pharmacol., 14:17 (Abstract).

[11] Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M., Eisenhofer, G., 1990. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol. Rev., 70(4):963-985.

[12] Esler, M.D., Thompson, J.M., Kaye, D.M., Turner, A.G., Jennings, G.L., Cox, H.S., Lambert, G.W., Seals, D.R., 1995. Effects of ageing on the responsiveness of the human cardiac sympathetic nerves to stressors. Circulation, 91(2):351-358.

[13] Ferrara, N., Bohm, M., Zolk, O., O'Gara, P., Harding, S.E., 1997. The role of Gi-proteins and β-adrenoceptors in the age-related decline of contraction in Guinea-pig ventricular myocytes. J. Mol. Cell. Cardiol., 29(2):439-448.

[14] Francis, G.S., 1995. Receptor systems involved in norepinephrine release in heart failure focus on dopaminergic systems. Clin. Cardiol., 18(Suppl. I): 13-16.

[15] Guimaraes, J.T., Paiva, M.Q., Moura, D., Guimaraes, S., 1998. Influence of maturation and ageing on the biotransformation of noradrenaline in the rat. J. Neural. Transm., 52(Suppl.):225-232.

[16] Hardouin, S., Mansier, P., Bertin, B., Dakhly, T., Swynghedauw, B., Moalic, J.M., 1997. Beta-adrenergic and muscarinic receptor expression are regulated in opposite ways during senescence in rat left ventricle. J. Mol. Cell. Cardiol., 29(1):309-319.

[17] Hata, J.A., Williams, M.L., Koch, W.J., 2004. Genetic manipulation of myocardial β-adrenergic receptor activation and desensitization. J. Mol. Cell. Cardiol., 37(1):11-21.

[18] Himura, Y., Felten, S.Y., Kashiki, M., Lewandowski, T.J., Delehanty, J.M., Liang, C.S., 1993. Cardiac noradrenergic nerve terminal abnormalities in dogs with experimental congestive heart failure. Circulation, 88(3): 1299-1309.

[19] Ideker, T., Thorsson, V., Ranish, J.A., Christmas, R., Buhler, J., Eng, J.K., Bumgarner, R., Goodlett, D.R., Aebersold, R., Hood, L., 2001. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science, 292(5518):929-934.

[20] Kawano, H., Okada, R., Yano, K., 2003. Histological study on the distribution of autonomic nerves in the human heart. Heart Vessels, 18(1):32-39.

[21] Kaye, D., Esler, M., 2005. Sympathetic neuronal regulation of the heart in aging and heart failure. Cardiovasc. Res., 66(2):256-264.

[22] Kitayama, S., Ikeda, T., Mitsuhata, C., Sato, T., Morita, K., Dohi, T., 1999. Dominant negative isoform of rat norepinephrine transporter produced by alternative RNA splicing. J. Biol. Chem., 274(16):10731-10736.

[23] Kiyono, Y., Kanegawa, N., Kawashima, H., Iida, Y., Kinoshita, T., Tamaki, N., Nishimura, H., Ogawa, M., Saji, H., 2002. Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging. Nuclear Med. Biol., 29(6):679-684.

[24] Lakatta, E.G., 1993. Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation, 87(2):631-636.

[25] Leenen, F.H.H., 2007. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ. Res., 101(3):221-223.

[26] Leineweber, K., Wangemann, T., Giessler, C., Bruck, H., Dhein, S., Kostelka, M., Mohr, F.W., Silber, R.E., Brodde, O.E., 2002. Age-dependent changes of cardiac neuronal noradrenaline reuptake transporter (uptake1) in the human heart. J. Am. Coll. Cardiol., 40(8):1459-1465.

[27] Li, H., Ma, S.K., Hu, X.P., Zhang, G.Y., Fei, J., 2001. Norepinephrine transporter (NET) is expressed in cardiac sympathetic ganglia of adult rat. Cell. Res., 11(4): 317-320.

[28] Li, S.T., Holmes, C., Kopin, I.J., Goldstein, D.S., 2003. Aging-related changes in cardiac sympathetic function in humans, assessed by 6-18F-fluorodopamine PET scanning. J. Nucl. Med., 44(10):1599-1603.

[29] Liang, C.S., Fan, T.H.W., Sullebarger, J.T., Sakamoto, S., 1989. Decreased adrenergic neuronal uptake activity in experimental right heart failure. J. Clin. Invest., 84(4): 1267-1275.

[30] Mehra, A., Lee, K.H., Hatzimanikatis, V., 2003. Insights into the relation between mRNA and protein expression patterns: I. Theoretical considerations. Biotech. Bioeng., 84(7):822-833.

[31] Pardini, B.J., Lund, D.D., Schmid, P.G., 1989. Organization of the sympathetic postganglionic innervation of the rat heart. J. Auton. Nerv. Syst., 28(3):193-202.

[32] Pardini, B.J., Lund, D.D., Schmid, P.G., 1990. Innervation patterns of the middle cervical-stellate ganglion complex in the rat. Neurosci. Lett., 117(3):300-306.

[33] Povlock, S.L., Amara, S.G., 1997. The Structure and Function of Norepinephrine, Dopamine, and Serotonin Transporters. In: Reith, M.E.A. (Ed.), Neurotransmitter Transporters: Structure, Function, and Regulation. Humana Press Inc., New Jersey, p.1-28.

[34] Rosen, S.D., Murphy, K., Leff, A.P., Cunningham, V., Wise, R.J.S., Adams, L., Coats, A.J.S., Camici, P.G., 2004. Is central nervous system processing altered in patients with heart failure? Eur. Heart J., 25(11):952-962.

[35] Sakai, M., Danziger, R.S., Xiao, R.P., Spurgeon, H.A., Lakatta, E.G., 1992. Contractile response of individual cardiac myocytes to norepinephrine declines with senescence. Am. J. Physiol., 262(1 pt 2):184-189.

[36] Seals, D.R., Esler, M.D., 2000. Human ageing and the sympathoadrenal system. J. Physiol., 528(3):407-417.

[37] Shores, M.M., White, S.S., Veith, R.C., Szot, P., 1999. Tyrosine hydroxylase mRNA is increased in old age and norepinephrine uptake transporter mRNA is decreased in middle age in locus coeruleus of Brown-Norway rats. Brain. Res., 826(1):143-147.

[38] Snyder, D.L., Aloyo, V.J., Wang, W., Roberts, J., 1998. Influence of age and dietary restriction on norepinephrine uptake into cardiac synaptosomes. J. Cardiovasc. Pharmacol., 32(6):896-901.

[39] Tumer, N., Scarpace, P.J., Baker, H.V., Larochelle, J.S., 1997. AP-1 transcription factor binding activity in rat adrenal medulla and hypothalamus with age and cold exposure. Neuropharmacology, 36(8):1065-1069.

[40] Ungerer, M., Chlistalla, A., Richardt, G., 1996. upregulation of cardiac uptake1, carrier in ischemic and nonischemic rat heart. Circ. Res., 78(6):1037-1043.

[41] Wehrwein, E.A., Parker, L.M., Wright, A.A., Spitsbergen, J.M., Novotny, M., Babankova, D., Swain, G.M., Habecker, B.A., Kreulen, D.L., 2008. Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content. Am. J. Physiol. Regul. Integr. Comp. Physiol., 295(3):R857-R863.

[42] White, M., Roden, R., Minobe, W., Khan, M.F., Larrabee, P., Wollmering, M., Port, J.D., Anderson, F., Campbell, D., Feldman, A.M., 1994. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation, 90(3):1225-1238.

[43] Wright, A.A., Wehrwein, E.A., Fink, G.D., Kreulen, D.L., 2006. Norepinephrine transporter protein does not correlate with sympathetic innervation density in the heart. FASEB J., 20:A1201 (Meeting Abstract).

[44] Xiao, R.P., Tomhave, E.D., Wang, D.J., Ji, X., Boluyt, M.O., Cheng, H., Lakatta, E.G., Koch, W.J., 1998. Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J. Clin. Invest., 101(6):1273-1282.

[45] Zahniser, N.R., Doolen, S., 2001. Chronic and acute regulation of Na⁺/Cl^–-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Therap., 92(1):21-55.

[46] Zhu, M.Y., Wang, W.P., Iyo, A.H., Ordway, G.A., Kim, K.S., 2005. Age-associated changes in mRNA levels of Phox2, norepinephrine transporter and dopamine β-hydroxylase in the locus coeruleus and adrenal glands of rats. J. Neurochem., 94(3):828-838.